This session will discuss EU Good Pharmacovigilance Practices (GVP) which are a set of measures drawn up to facilitate the performance of the safety monitoring of medicines in the European Union.

Have an account?

Pragmatic Approaches to Drug Safety Across the Premarketing and Postmarketing Continuum

Session 16: Postmarketing Safety Regulations – EU

Session Chair(s)

Jill W. Buckley, PharmD

Be informed and stay engaged.